Navigation Links
Charting the Biosimilar and Biobetter Development Pipeline
Date:9/20/2012

and greatest potential opportunity

Concise commentary highlighting key findings, and providing valuable market intelligence

Definitions of key terms and concepts

 

 

 

Key Benefits

 

Understand the universe of biosimilar and biobetter development

Get the complete picture of all products in the biosimilar pipeline

Know the latest status on specific biosimilar andbiobetter products of interest to you

Read about the most significant developments in every therapeutic area

Discover the levels of potential biosimilar and biobetter competition by therapy area and drug class

Analyze the size of the threat to your company's biologic portfolio

Learn which companies are potential future competitors

 

 

Key Questions Answered

When is the earliest potential launch for "Biosimilar X"?

What biosimilars are being developed in each therapeutic area, drug class, and compound class?

Which reference products are most targeted by biosimilar and biobetter developers?

Is the reference product sales value the key factor shaping biosimilar development priorities?

Which therapy areas are going to experience the most and fewest biosimilar entries?

Which companies are most active in the biosimilar and biobetter arena?

Which biosimilar companies have been most successful in getting their products onto the market?

How many new biosimilars will be on the market by 2014?

 

Who Would Benefit From This Report?

Strategic executives at originator, generic, and biosimilar/biobetter development companies, especially in:

 

Sales and Marketing

Regulatory Affairs

IP and Patent Affairs

Market Research

Research & Development

Business Development

Medical Communications

 

 <
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology news :

1. Newly released FDA draft guidelines for biosimilar drugs to be discussed at conference
2. Artificial womb unlocks secrets of early embryo development
3. REST is crucial for the timing of brain development
4. Embryonic development protein active in cancer growth
5. Scientists win $2 million to study new pathway in development and maintenance of lymphoma
6. Stomata development in plants unraveled -- a valuable discovery for environmental research
7. Promising developments in early diagnosis and treatment of mesothelioma
8. Europe meets to discuss progress in energy research and development
9. Gut microbiota transplantation may prevent development of diabetes and fatty liver disease
10. New genes contributing to autism and related neurodevelopmental disorders uncovered
11. Michael J. Fox Foundation grant to Dr. Samuel Young will provide Parkinsons drug development tools
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... BOSTON , April 1, 2015   Medisafe ... 1.5 million users across iOS and ... has begun integrating biofeedback into the platform to allow ... health outcomes. For the first time, patients will be ... missing a dose impacts important biometrics, such as glucose ...
(Date:3/31/2015)... --  Guidepoint , a leading global research services firm, ... TRACKER, part of the Guidepoint TRACKER suite ... device and therapeutics markets. The Post-Surgical Pain Management TRACKER ... share, and adoption rates across three major modalities used ... The Post-Surgical Pain Management TRACKER will provide length ...
(Date:3/26/2015)... -- The Granite Club, Canada,s ... today announced it has implemented a state-of-the-art access and ... members and staff, while restricting access to authorized users ... FST,s IMID Access system because it has the perfect ... staff, in addition to unparalleled security," said James ...
Breaking Biology News(10 mins):Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2
... The psychological impact of natural disasters such as ... people inherently respond to unpredictable situations, according to a ... Dr Magda Osman, Psychology Lecturer at Queen Mary, University ... Learning in Complex Worlds, said the disaster had a ...
... pager or cell phone three times, that would be your best ... simple tissue moistened with saline would do the trick. But if ... phone you,d be better off reaching for a disinfectant wipe. ... that appeared online in PubMed , with the discoveries having ...
... observe behavior in fossil specimens that are dead even ... modern, living, species that has some similarities to the ancient ... University of Cincinnati professor of geology and colleagues as they ... they resemble clams or other shelled mollusks, brachiopods are more ...
Cached Biology News:Psychological impact of Japan disaster will be felt 'for some time to come' 2Bacterial wipes research study 2Paleontologists audition modern examples of ancient behavior 2
(Date:4/20/2015)... -- "Everybody is affected by cancer sooner or later," Dr. ... We,ve got to get away from that."  If you,ve ... loved one or friend battling for their life against ... other treatments cause the human body. It,s almost enough ... succumb to the disease. Dr. Dionne has developed a ...
(Date:4/20/2015)... , April 20, 2015   Meditope Biosciences, Inc ... its proprietary technology, today announced presentation of data demonstrating ... development of antibody-drug conjugates (ADCs). The data were presented in ... place April 18-22 in Philadelphia . ... data which point to the many commercial applications that ...
(Date:4/17/2015)... April 17, 2015  Centrillion Technologies, a ... grant from the National Human Genome Research ... Health (NIH). The grant will help fund ... development of breakthrough genomic technologies, including phased ... substrates. Centrillion has been developing this transformative ...
(Date:4/17/2015)... 17, 2015  Guggenheim Securities, the investment banking and ... hiring of William Tanner as a Managing ... Tanner will start work at Guggenheim in May 2015 ... office. "Bill brings a wealth of biotech ... experienced and highly acclaimed healthcare team," said Matthew ...
Breaking Biology Technology:Is Dr. Craig Dionne the Steve Jobs of Cancer Research? 2Meditope Biosciences Presents Data At The American Association Of Cancer Research (AACR) Annual Meeting Validating Its SnAP Technology Platform 2Guggenheim Securities Hires Biotech Analyst William Tanner in Expansion of Healthcare Coverage 2
... Tengion Inc., a clinical stage regenerative medicine company focused on ... M.D., President and Chief Executive Officer of Tengion, will present at ... 2008 at 9:50 a.m. EST at The Palace Hotel in New ... About Tengion , , ...
... 25 Indevus,Pharmaceuticals, Inc. (Nasdaq: IDEV ) today ... the three-month period ended September,30, 2008. The Company will ... eastern time (details follow below). , ... $77.8 million,an increase of 18% from fiscal 2007 revenues of ...
... ANN ARBOR, Mich., Nov. 24 Terumo Heart, Inc. ... the position of Chief Executive,Officer (C.E.O.) and President, effective ... for a strong leadership role in,the future treatment of ... enrollment in the DuraHeart U.S. Pivotal trials in up ...
Cached Biology Technology:Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 2Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 3Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 4Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 5Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 6Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 7Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 8Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 9Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 10Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 11Terumo Heart Announces Appointment of William Pinon to Chief Executive Officer and President 2
Purified Mouse anti-Hu LAT (pY226) Storage Temperature: Refrigerate(2 to 8C)...
Tris-EDTA Buffer Solution, 1X, pH 8.0, sterile, Molecular Biology Grade...
... Signet offers the most comprehensive, cost-effective ... We have incorporated unprecedented quality into ... This includes proven detection chemistries and ... the TechMate protocol. It also includes ...
...
Biology Products: